Subtopic Deep Dive
Leishmaniasis Epidemiology and Global Burden
Research Guide
What is Leishmaniasis Epidemiology and Global Burden?
Leishmaniasis Epidemiology and Global Burden studies the worldwide incidence, prevalence, risk factors, and socioeconomic impacts of leishmaniasis using surveillance data and modeling.
This subtopic estimates 0.9–1.7 million new cases annually across 98 countries (Alvar et al., 2012, 5055 citations). It examines urban expansion and poverty as drivers of transmission (Desjeux, 2001, 1027 citations; Alvar et al., 2006, 819 citations). Over 30 papers from WHO experts provide case data from endemic regions.
Why It Matters
Global burden estimates guide WHO elimination targets, prioritizing visceral leishmaniasis control in India and East Africa (Alvar et al., 2012). Socioeconomic analyses link poverty to 20-fold higher incidence in poor communities, informing resource allocation (Alvar et al., 2006). HIV coinfection data from 2000 cases in Europe highlight dual epidemic risks, shaping integrated interventions (Alvar et al., 2008). Urban risk factor mapping supports vector control in megacities (Desjeux, 2001).
Key Research Challenges
Underreporting in Endemic Areas
National surveillance misses 70–90% of cases due to asymptomatic infections and weak health systems (Alvar et al., 2012). Modeling relies on expert inputs from 88 countries, introducing bias. Improved passive reporting systems are needed.
Quantifying Socioeconomic Drivers
Poverty and urbanization amplify transmission, but metrics vary across regions (Alvar et al., 2006; Desjeux, 2001). No standardized indices link income to incidence rates. Longitudinal studies are scarce.
Forecasting Coinfection Risks
Leishmania-HIV overlaps exceed 2000 cases in Europe, with unclear global scale (Alvar et al., 2008). Vector dynamics complicate predictions. Integrated epidemiological models lag.
Essential Papers
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar, Iván Darío Vélez, Caryn Bern et al. · 2012 · PLoS ONE · 5.1K citations
As part of a World Health Organization-led effort to update the empirical evidence base for the leishmaniases, national experts provided leishmaniasis case data for the last 5 years and information...
Leishmaniasis: current situation and new perspectives
P. Desjeux · 2004 · Comparative Immunology Microbiology and Infectious Diseases · 2.3K citations
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
François Chappuis, Shyam Sundar, Asrat Hailu et al. · 2007 · Nature Reviews Microbiology · 1.5K citations
The immunology of susceptibility and resistance to Leishmania major in mice
David L. Sacks, Nancy Noben-Trauth · 2002 · Nature reviews. Immunology · 1.2K citations
The increase in risk factors for leishmaniasis worldwide
P. Desjeux · 2001 · Transactions of the Royal Society of Tropical Medicine and Hygiene · 1.0K citations
Economic development leads to changing interactions between humans and their physical and biological environment. Worldwide patterns of human settlement in urban areas have led in developing countr...
Leishmaniasis: a review
Edoardo Torres‐Guerrero, Marco Romano Quintanilla-Cedillo, Julieta Ruiz-Esmenjaud et al. · 2017 · F1000Research · 996 citations
<ns4:p>Leishmaniasis is caused by an intracellular parasite transmitted to humans by the bite of a sand fly. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide, 1....
A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies
Mohammad Akhoundi, Katrin Kuhls, Arnaud Cannet et al. · 2016 · PLoS neglected tropical diseases · 973 citations
We propose an updated view of events that have played important roles in the geographical dispersion of sandflies, in relation to both the Leishmania species they transmit and the animal reservoirs...
Reading Guide
Foundational Papers
Start with Alvar et al. (2012) for global incidence baselines from WHO data, then Desjeux (2001) for risk factors, and Alvar et al. (2006) for poverty links.
Recent Advances
Torres-Guerrero et al. (2017, 996 citations) reviews current endemicity; Akhoundi et al. (2016, 973 citations) traces parasite dispersion.
Core Methods
Surveillance aggregation from national experts, incidence modeling with confidence intervals, risk factor analysis via urbanization and poverty indices (Alvar et al., 2012; Desjeux, 2001).
How PapersFlow Helps You Research Leishmaniasis Epidemiology and Global Burden
Discover & Search
Research Agent uses searchPapers and citationGraph on 'Alvar et al. 2012' to map 5000+ citing works on incidence estimates, then exaSearch for 'leishmaniasis urban risk factors' uncovers Desjeux 2001 clusters.
Analyze & Verify
Analysis Agent applies readPaperContent to extract case data from Alvar et al. 2012, runs verifyResponse with CoVe for burden claims, and runPythonAnalysis with pandas to verify incidence trends (e.g., 95% CI: 0.9–1.7M cases); GRADE scores evidence as high for WHO estimates.
Synthesize & Write
Synthesis Agent detects gaps in coinfection forecasting post-Alvar 2008, flags contradictions in urban risk models; Writing Agent uses latexEditText, latexSyncCitations for burden review, and latexCompile for publication-ready tables.
Use Cases
"Analyze incidence trends from Alvar 2012 using Python"
Research Agent → searchPapers('Alvar 2012') → Analysis Agent → readPaperContent → runPythonAnalysis(pandas plot of cases by region) → matplotlib incidence graph.
"Write LaTeX review of leishmaniasis poverty links"
Synthesis Agent → gap detection(Alvar 2006) → Writing Agent → latexEditText(draft) → latexSyncCitations(Desjeux 2001) → latexCompile(PDF with burden table).
"Find code for leishmaniasis GIS modeling"
Research Agent → citationGraph(Alvar 2012) → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(R scripts for incidence mapping) → exportCsv(data export).
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'leishmaniasis incidence', structures WHO-aligned burden report with GRADE grading. DeepScan applies 7-step CoVe to verify risk factors from Desjeux 2001 against recent citers. Theorizer generates hypotheses on urbanization impacts from Alvar 2012 abstracts.
Frequently Asked Questions
What is the global incidence of leishmaniasis?
Alvar et al. (2012) estimate 0.9–1.7 million new cases yearly across 98 countries, based on expert data from 88 nations.
What methods estimate leishmaniasis burden?
WHO-led efforts aggregate national case reports, treatment data, and modeling for 5-year trends (Alvar et al., 2012). Surveillance integrates passive reporting and expert validation.
What are key papers on leishmaniasis epidemiology?
Alvar et al. (2012, 5055 citations) provides global estimates; Desjeux (2001, 1027 citations) details risk factors; Alvar et al. (2006, 819 citations) links poverty to burden.
What open problems exist in burden estimation?
Underreporting (70–90% missed cases), unstandardized socioeconomic metrics, and scaling HIV coinfections beyond Europe remain unresolved (Alvar et al., 2012; Alvar et al., 2008).
Research Research on Leishmaniasis Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Leishmaniasis Epidemiology and Global Burden with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Research on Leishmaniasis Studies Research Guide